Facetten
Zugriff
Einrichtung
Medientyp
- Text 11
Karte
Erscheinungsjahr
Autor/in
- Bacher, Ulrike
- Badbaran, Anita
- Kröger, Nicolaus 9
- Wolschke, Christine 6
- Fehse, Boris 5
- alle zeigen
Sprache
11 Einträge gefunden
-
Post-Transplantation Day +100 Minimal Residual Disease Detection Rather Than Mixed Chimerism Predicts Relapses after Allogeneic Stem Cell Transplantation for Intermediate-Risk Acute Myelogenous Leukemia Patients Undergoing Transplantation in Complete Remission
- Klyuchnikov, Evgeny
- Badbaran, Anita
- Massoud, Radwan
- Fritzsche-Friedland, Ulrike
- Freiberger, Petra
- Ayuk, Francis
- Wolschke, Christine
-
Post-Transplantation Multicolored Flow Cytometry-Minimal Residual Disease Status on Day 100 Predicts Outcomes for Patients With Refractory Acute Myeloid Leukemia
- Klyuchnikov, Evgeny
- Badbaran, Anita
- Massoud, Radwan
- Fritsche-Friedland, Ulrike
- Janson, Dietlinde
- Ayuk, Francis
- Christopeit, Maximilian
-
Enhanced Immune Reconstitution of γδ T Cells after Allogeneic Stem Cell Transplantation Overcomes the Negative Impact of Pretransplantation Minimal Residual Disease-Positive Status in Patients with Acute Myelogenous Leukemia
- Klyuchnikov, Evgeny
- Badbaran, Anita
- Massoud, Radwan
- Fritsche-Friedland, Ulrike
- Janson, Dietlinde
- Ayuk, Francis
- Wolschke, Christine
-
Role of pre-transplant MRD level detected by flow cytometry in recipients of allogeneic stem cell transplantation with AML
- Klyuchnikov, Evgeny
- Christopeit, Maximilian
- Badbaran, Anita
- Bacher, Ulrike
- Fritsche-Friedland, Ulrike
- von Pein, Ute-Marie
- Wolschke, Christine
-
Postallogeneic monitoring with molecular markers detected by pretransplant next-generation or Sanger sequencing predicts clinical relapse in patients with myelodysplastic/myeloproliferative neoplasms
- Fu, Yuewen
- Schroeder, Thomas
- Zabelina, Tatiana
- Badbaran, Anita
- Bacher, Ulrike
- Kobbe, Guido
- Ayuketang, Francis Ayuk
-
-
JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation.
- Kröger, Nicolaus
- Alchalby, Haefaa
- Klyuchnikov, Evgeny
- Badbaran, Anita
- Hildebrandt, York
- Ayuketang Ayuk, Francis
- Bacher, Ulrike
-
Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.
- Kröger, Nicolaus
- Badbaran, Anita
- Lioznov, Michael
- Schwartz, Sabine
- Zeschke, Silke
- Hildebrandt, York
- Ayuketang Ayuk, Francis
-
Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.
- Lioznov, Michael
- El-Cheikh, J
- Hoffmann, Friedericke
- Hildebrandt, York
- Ayuketang Ayuk, Francis
- Wolschke, Christine
- Atanackovic, Djordje
-
-
Bone marrow mesenchymal stromal cells remain of recipient origin after allogeneic SCT and do not harbor the JAK2V617F mutation in patients with myelofibrosis.
- Bacher, Ulrike
- Asenova, Svetlana
- Badbaran, Anita
- Zander, Axel R.
- Alchalby, Haefaa
- Fehse, Boris
- Kröger, Nicolaus